WellSpring Consumer Healthcare Strengthens Its Product Range
WellSpring Consumer Healthcare, a trusted name in OTC and personal care products, is making waves in the skincare sector. In a bold move to elevate its position in therapeutic skincare, WellSpring has acquired two well-known brands, DerMend® and Recticare®, from Ferndale Pharma Group. This acquisition promises to both diversify and solidify WellSpring’s standing in the competitive skincare market.
The Power of Established Brands
DerMend® and Recticare® are prominent names recognized for their quality and effectiveness. DerMend® is particularly known for its dermatologist-recommended topical creams tailored for aging, fragile, or bruised skin, ensuring users have access to high-quality skin care solutions. Meanwhile, Recticare® provides quick and effective relief for those experiencing hemorrhoidal discomfort, making it a valuable addition to WellSpring's portfolio.
Expanding Distribution Channels
The collaboration with Ferndale Brands enhances WellSpring's distribution capability, as their products are already available through leading retailers and online platforms. This ensures that consumers nationwide can easily access these trusted therapeutic solutions, driving both brand visibility and sales growth.
CEO's Vision for the Future
Chris Brown, the CEO of WellSpring, expressed his enthusiasm about this strategic acquisition, citing the synergy between WellSpring’s mission and the quality of products offered by Ferndale Brands. Brown remarked, "The addition of the Ferndale Brands represents a significant step in strengthening WellSpring's portfolio of trusted OTC and personal care solutions. These brands align seamlessly with our commitment to deliver high-quality products that meet consumers' evolving health and wellness needs."
A Look at WellSpring's Growth Strategy
This acquisition marks a pivotal moment, being the third add-on acquisition since Avista Healthcare Partners' initial investment in 2022. It follows the successful procurement of A+D® and Solarcaine® from Bayer AG in 2023, along with the acquisition of vH essentials® from Wisconsin Pharmacal Company in 2024. Each strategic move has been essential in enhancing WellSpring’s market presence and growth trajectory.
WellSpring's Expansive Portfolio
Founded in 1999, WellSpring develops a diversified range of OTC brands in both the U.S. and Canada. Their portfolio includes various leading products in therapeutic skincare, digestive health, and women's health. Noteworthy therapeutic skincare brands include A+D® for diaper rash, Bactine® for germ-focused care, and others that provide effective solutions for specific health concerns.
About WellSpring Consumer Healthcare
WellSpring Consumer Healthcare, based in Sarasota, Florida, has built a reputation for delivering diversified and reliable OTC solutions. Their strategic approach combines rigorous product innovation, an agile distribution network, and a commitment to meeting consumer health needs. Interested parties can discover more about WellSpring's offerings through their official website.
About Avista Healthcare Partners
Founded in 2005, Avista Healthcare Partners boasts a robust investment portfolio with over $10 billion invested in healthcare businesses worldwide. Specializing in backing companies with strong management teams and significant growth potential, Avista's expertise has been instrumental in guiding businesses towards fulfilling their operational and financial goals.
Contact Information for Media Inquiries
For further inquiries, media representatives can contact:
Daniel Yunger / James Lindsay
Kekst CNC
917.574.8582 / 917.842.4119
Frequently Asked Questions
What brands has WellSpring recently acquired?
WellSpring has recently acquired DerMend® and Recticare®, enhancing its portfolio in therapeutic skincare.
How does DerMend® assist consumers?
DerMend® offers dermatologist-recommended topical creams to aid aging and fragile skin, promoting overall skin health.
What is WellSpring's mission?
WellSpring's mission is to provide high-quality OTC and personal care solutions that meet evolving consumer health needs.
Who is the CEO of WellSpring Consumer Healthcare?
The CEO of WellSpring Consumer Healthcare is Chris Brown, who leads the company's growth and product strategy.
What is Avista Healthcare Partners' focus?
Avista Healthcare Partners focuses on investing in healthcare businesses that demonstrate strong management and growth potential while targeting key sectors in the industry.
